Folate (Vitamin B9): Clinical Evidence & Substantiation Summary
What Is Folate (Vitamin B9)?
Folate is a water-soluble B vitamin essential for DNA synthesis, cell division, and amino acid metabolism. It is especially critical during pregnancy for neural tube development. The active form, 5-MTHF (methylfolate), bypasses the need for MTHFR enzyme conversion.
Mechanism of action: Folate serves as a one-carbon donor in methylation reactions critical for DNA synthesis (thymidylate and purine production), amino acid metabolism (homocysteine to methionine conversion), and epigenetic regulation. The MTHFR gene polymorphism (C677T) affects folate metabolism in approximately 10–15% of the population.
Clinical Evidence Summary
Below are 5 key clinical studies on Folate (Vitamin B9). Nutra Comp analyses 94+ studies in its full clinical evidence report.
Folic acid supplementation and neural tube defect prevention
Population: 5 RCTs, 6,105 women
Key finding: Folic acid supplementation before conception and during early pregnancy reduced neural tube defect risk by 72% (RR 0.28, 95% CI 0.15–0.52).
Folate and homocysteine: a dose-response meta-analysis
Population: 25 RCTs
Key finding: Folate supplementation reduced homocysteine by 25% on average (p<0.001), with 5-MTHF showing superior effects in MTHFR C677T carriers.
5-MTHF vs folic acid: comparative efficacy
Population: 144 women
Key finding: 5-MTHF increased red blood cell folate more effectively than folic acid in women with MTHFR polymorphism (p=0.02).
Folate and cardiovascular risk reduction
Population: 30 RCTs
Key finding: Folic acid supplementation reduced stroke risk by 10% (RR 0.90, 95% CI 0.84–0.97), with greater effects in regions without mandatory fortification.
Folate and depression: a systematic review
Population: 11 studies
Key finding: Low folate status was associated with increased depression risk. Supplementation with methylfolate showed adjunctive benefits in treatment-resistant depression.
Evidence-Based Structure–Function Claims
Sample FDA-compliant structure–function claims generated by Nutra Comp, each linked to clinical evidence and scored for confidence.
Get the full substantiation report for Folate (Vitamin B9)
Includes all 94+ clinical studies analysed, complete claims library, and a ready-to-file substantiation memo.
Join Waitlist for Full AccessRelated Ingredients
Key Terms
Frequently Asked Questions
Is folate FDA approved?
Folate is an essential B vitamin sold as a dietary supplement. The FDA has established a Daily Value of 400 mcg DFE. Folic acid in prenatal supplements is widely recommended by health organisations.
What is the difference between folic acid and methylfolate?
Folic acid is the synthetic form that must be converted to 5-MTHF by the MTHFR enzyme. Methylfolate (5-MTHF) is the active form that bypasses this conversion, beneficial for those with MTHFR gene variants affecting enzyme efficiency.
What dosage of folate is used in clinical studies?
The DV is 400 mcg DFE. Prenatal doses are typically 400–800 mcg. Higher doses (1,000–15,000 mcg) of methylfolate have been studied for mood support, particularly in treatment-resistant depression.
Stop Spending Weeks on Substantiation
Nutra Comp generates full clinical evidence reports, FDA-compliant structure–function claims, and substantiation memos in minutes — not months.
Join the Waitlist